Genetic disruption of Pten in a novel mouse model of tomaculous neuropathy.
about
Balancing Proliferation and Connectivity in PTEN-associated Autism Spectrum DisorderNew insights on Schwann cell developmentMicroRNA-23a promotes myelination in the central nervous systemMotor and sensory neuropathy due to myelin infolding and paranodal damage in a transgenic mouse model of Charcot-Marie-Tooth disease type 1C.Lck tyrosine kinase mediates β1-integrin signalling to regulate Schwann cell migration and myelinationMetabolic regulator LKB1 is crucial for Schwann cell-mediated axon maintenance.Pten loss in Olig2 expressing neural progenitor cells and oligodendrocytes leads to interneuron dysplasia and leukodystrophy.Abnormal junctions and permeability of myelin in PMP22-deficient nerves.Late onset neuropathy with spontaneous clinical remission in mice lacking the POZ domain of the transcription factor Myc-interacting zinc finger protein 1 (Miz1) in Schwann cellsInvolvement of phosphatase and tensin homolog deleted from chromosome 10 in rodent model of neuropathic pain.Regulation of Peripheral Nerve Myelin Maintenance by Gene Repression through Polycomb Repressive Complex 2The Polarity Protein Pals1 Regulates Radial Sorting of AxonsHypomyelination following deletion of Tsc2 in oligodendrocyte precursors.Myelin is dependent on the Charcot-Marie-Tooth Type 4H disease culprit protein FRABIN/FGD4 in Schwann cellsThe CMT4B disease-causing phosphatases Mtmr2 and Mtmr13 localize to the Schwann cell cytoplasm and endomembrane compartments, where they depend upon each other to achieve wild-type levels of protein expression.Reversing hypomyelination in BACE1-null mice with Akt-DD overexpression.Neurological dysfunctions associated with altered BACE1-dependent Neuregulin-1 signaling.Akt Regulates Axon Wrapping and Myelin Sheath Thickness in the PNSGenetic deletion of Cadm4 results in myelin abnormalities resembling Charcot-Marie-Tooth neuropathy.Strength of ERK1/2 MAPK Activation Determines Its Effect on Myelin and Axonal Integrity in the Adult CNS.Schwann Cell O-GlcNAc Glycosylation Is Required for Myelin Maintenance and Axon Integrity.Niacin-mediated Tace activation ameliorates CMT neuropathies with focal hypermyelination.DDIT4/REDD1/RTP801 is a novel negative regulator of Schwann cell myelination.Genetic heterogeneity of motor neuropathiesNegative regulators of schwann cell differentiation-novel targets for peripheral nerve therapies?Signaling mechanisms regulating myelination in the central nervous system.Akt/mTOR signalling in myelination.Concepts for regulation of axon integrity by enwrapping glia.Brain patterning perturbations following PTEN loss.Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseasesSchwann cell myelinationDysregulation of ErbB Receptor Trafficking and Signaling in Demyelinating Charcot-Marie-Tooth Disease.mTORC1 promotes proliferation of immature Schwann cells and myelin growth of differentiated Schwann cells.Molecular Mechanisms Involved in Schwann Cell PlasticitySchwann cell development, maturation and regeneration: a focus on classic and emerging intracellular signaling pathwaysDual function of the PI3K-Akt-mTORC1 axis in myelination of the peripheral nervous system.Activation of MAPK overrides the termination of myelin growth and replaces Nrg1/ErbB3 signals during Schwann cell development and myelination.Merlin controls the repair capacity of Schwann cells after injury by regulating Hippo/YAP activity.Giant scaffolding protein AHNAK1 interacts with β-dystroglycan and controls motility and mechanical properties of Schwann cells.Therapeutic implications of protein homeostasis in demyelinating peripheral neuropathies.
P2860
Q26822064-64BD75D1-544E-4DD8-959D-34888EA3F25EQ28083538-FEBE1A88-9ADF-420E-AB40-B47849AA9816Q28589529-D1F4EFE6-CB71-4294-B588-BF98C4355669Q30538247-B067AECE-28E4-47D6-A63A-0010BDF0100FQ30540349-18190E88-603D-4146-A900-D3FD40CC0105Q30656970-2281D791-B78C-4E20-AA83-CB3BE8A133F1Q33895438-56C5145C-873F-4EF0-92A5-D6FC0CD61226Q34386936-4C3D626B-88B5-44CD-AC31-A371819054E0Q34958666-3ECB1141-0527-4E17-8DC8-9CE66AAD9CA2Q35276335-5949BBF6-A408-4C48-AC45-7CF5FDE036D6Q35675222-DDE02B0D-DCC1-45B3-B663-E13E49F47E9BQ35876798-9FE99738-A28F-4250-A3C4-375E9D313AA0Q36410278-37A0CE44-D853-4155-BEBC-3FEC762CA2DBQ36474685-D017E3DA-D2D4-4571-B3B4-8961563C88A8Q36709124-477F9364-75FA-450E-BFF2-DA5D85C27064Q36788760-58A9E8B3-0F27-4DE9-863D-C89201ADEEACQ36804007-305ECE74-C7F7-4C86-A5AF-D47CFBC4A057Q36815701-41408461-3C43-40E3-A72A-426478334096Q37032402-590FA056-0536-40F6-8A5B-F4F70782E3EFQ37241744-FEFA94C9-A24A-4CC7-830A-85657039A4DDQ37290153-B9B402DA-0222-498B-9059-FD2E9ADC220EQ37514807-FB55C73C-650D-47F4-AC56-BF6A88DA5CB6Q37705373-EF4EC473-FAD7-4B67-B2DF-7749ABE6854BQ37730501-792028D6-DA52-48D3-8CE6-729FCAE91F99Q38041476-131A34D5-BD8F-4291-B5D9-1310E7B431EFQ38096247-465D220C-5748-49FC-AD1C-9FAFE85BCC7BQ38122225-B307485D-01EA-4B23-B83B-DAB0086F3DFAQ38175969-E3EF5963-ADBA-4B25-B8B8-22707648E394Q38214592-CBDAF1D9-E863-4E7C-88B7-ADAFCE9E3D0EQ38225912-F4DEB729-D273-4ADB-9481-0F5267E6F31AQ38520894-1C781DEA-F41F-4F9B-BE68-2511B922F5B5Q38687390-F66938B5-9A2A-4178-89C9-3440D0B13312Q38796987-3DD033AA-E6DA-47C9-BB35-C7122EF72DA4Q39162513-B230F4A8-5EA6-48FC-A447-D7CEB078047EQ41429732-BC8D833E-681B-444B-AFC3-04F53450B68DQ41560440-FBEC62B2-7511-4AA8-99CA-77FA96551AF5Q41954106-4F5570CF-C615-48B3-B9E8-4E002881FA06Q42323518-9F9FC468-FDF3-451B-8334-A375C14EB3CCQ42458390-2511586F-6DB2-4F0F-9B82-706680D920F4Q43046477-587DE96C-5637-4542-BF9F-6957CE47A67E
P2860
Genetic disruption of Pten in a novel mouse model of tomaculous neuropathy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Genetic disruption of Pten in a novel mouse model of tomaculous neuropathy.
@en
Genetic disruption of Pten in a novel mouse model of tomaculous neuropathy.
@nl
type
label
Genetic disruption of Pten in a novel mouse model of tomaculous neuropathy.
@en
Genetic disruption of Pten in a novel mouse model of tomaculous neuropathy.
@nl
prefLabel
Genetic disruption of Pten in a novel mouse model of tomaculous neuropathy.
@en
Genetic disruption of Pten in a novel mouse model of tomaculous neuropathy.
@nl
P2093
P2860
P356
P1476
Genetic disruption of Pten in a novel mouse model of tomaculous neuropathy.
@en
P2093
Alexander Pieper
Georg L Wieser
Jan H Oltrogge
Michael W Sereda
Sandra Goebbels
Susanne Wolfer
Tobias Nientiedt
Torben Ruhwedel
P2860
P304
P356
10.1002/EMMM.201200227
P577
2012-04-04T00:00:00Z